These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8091824

  • 41. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
    Yi GH, Burkhoff D, Zhang H, Zhu SM, Zwas D, Wang J.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
    [Abstract] [Full Text] [Related]

  • 42. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M, Warrington SJ, Boyce M, Johnston A, Bianchini C.
    J Cardiovasc Pharmacol; 1995 Aug; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [Abstract] [Full Text] [Related]

  • 43. [Clinico-pharmacologic aspects of therapy with enoximone].
    Trenk D, Jähnchen E.
    Z Kardiol; 1994 Aug; 83 Suppl 2():7-14. PubMed ID: 8091828
    [Abstract] [Full Text] [Related]

  • 44. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J, Buchholz C, Steinmetz M, Courtney M, Gass A, Lansman S, Kukin ML.
    J Heart Lung Transplant; 1995 Aug; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [Abstract] [Full Text] [Related]

  • 45. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?
    Talha S, Di Marco P, Doutreleau S, Rouyer O, Piquard F, Geny B.
    Clin Transplant; 2008 Aug; 22(5):542-8. PubMed ID: 18394002
    [Abstract] [Full Text] [Related]

  • 46. High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
    Schulz O, Mitrovic V, Schönburg M, Thormann J.
    Am Heart J; 1999 May; 137(5):887-94. PubMed ID: 10220638
    [Abstract] [Full Text] [Related]

  • 47. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
    Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT, Richards AM.
    J Am Coll Cardiol; 2007 Jan 30; 49(4):461-71. PubMed ID: 17258092
    [Abstract] [Full Text] [Related]

  • 48. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M, Tritto C, De Luca N, Mele AF, Lembo G, Rubattu S, Romano M, De Campora P, Enea I, Ricciardelli B.
    J Clin Invest; 1991 Nov 30; 88(5):1481-9. PubMed ID: 1834698
    [Abstract] [Full Text] [Related]

  • 49. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
    Coulaud JM, Faitg R, Poler F, Rezgui N, Besse B, Lissac J.
    Arch Mal Coeur Vaiss; 1990 Sep 30; 83 Spec No 3():51-6. PubMed ID: 2147835
    [Abstract] [Full Text] [Related]

  • 50. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y, Hasegawa K, Sawayama T, Inoue S, Nakamura T, Kakumae S, Tadaoka S, Nakao M, Nezuo S.
    Kokyu To Junkan; 1989 Dec 30; 37(12):1333-40. PubMed ID: 2575781
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V, Schlepper M, Neuzner J, Bahavar H, Volz M, Dieterich HA.
    Z Kardiol; 1988 Oct 30; 77(10):660-7. PubMed ID: 2977029
    [Abstract] [Full Text] [Related]

  • 54. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
    Berti S, Palmieri C, Ravani M, Bonini R, Iascone MR, Clerico A, Manfredi C, Iervasi G, Ferrazzi P, Biagini A.
    Cardiovasc Drugs Ther; 1996 Mar 30; 10(1):81-7. PubMed ID: 8723174
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA, Morris WM, Sole MJ.
    Can J Cardiol; 1987 Mar 30; 3(2):70-4. PubMed ID: 3567710
    [Abstract] [Full Text] [Related]

  • 57. [Continuous infusion of enoximone in the treatment of acute myocardial ischemia with low output syndrome].
    Sicignano A, Bellato V, Riboni A, Vesconi S.
    Minerva Anestesiol; 1994 Mar 30; 60(3):109-13. PubMed ID: 8090300
    [Abstract] [Full Text] [Related]

  • 58. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
    Mager G, Steffen HM, Klocke RK, Wambach G, Kux A, Degenhardt S, Höpp HW, Hilger HH.
    Z Kardiol; 1991 Apr 30; 80(4):272-8. PubMed ID: 1862668
    [Abstract] [Full Text] [Related]

  • 59. Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantation.
    Strametz-Juranek J, Pacher R, Kos T, Woloszczuk W, Grimm M, Zuckermann A, Stanek B.
    J Heart Lung Transplant; 2003 Jul 30; 22(7):731-7. PubMed ID: 12873540
    [Abstract] [Full Text] [Related]

  • 60. [Hemodynamic characteristics of heart transplant patients in the early postoperative period].
    Dammenhayn L, Haverich A, Coppola R, Albes J, Cremer J, Schäfers HJ, Wahlers T.
    Z Kardiol; 1991 Nov 30; 80(11):681-6. PubMed ID: 1792810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.